How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
July 6 - Hedge Funds, News - Comments
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
December 13 - Hedge Funds, News - Comments
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Keep Reading →
November 7 - Hedge Funds, News - Comments
US hedge fund Pentwater Capital has emerged as the buyer of the 23 per cent stake in Irish life science investment company Malin Corp that was sold in recent weeks by troubled...
Keep Reading →
October 8 - Hedge Funds, Insider Trading - Comments
In a message he wrote shortly before his death, the legendary oil magnate T.
Keep Reading →
September 20 - Hedge Funds, Insider Trading - Comments
Pershing Square bucks a down market with August gains.
Keep Reading →
September 4 - Hedge Funds, Insider Trading - Comments
BOSTON (Reuters) - Billionaire investor Daniel Loeb said on Friday that his hedge fund Third Point LLC will vote against the planned merger of United Technologies Corp (UTX.N) ...
Keep Reading →
June 28 - Hedge Funds, Insider Trading - Comments
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 27 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Keep Reading →
May 9 - Hedge Funds, News - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
August 1 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 25 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 15 - Hedge Funds - Comments
It’s been a busy quarter in the biotechnology space, but it’s not over yet.
Keep Reading →
March 14 - News, Stock Analysis - Comments
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and Palatin Technologies, Inc.
Keep Reading →
January 10 - Market Movers, News, Stock Analysis - Comments
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Keep Reading →
November 29 - Hedge Funds, News - Comments
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) took a big hit yesterday, as the company announced its second-quarter earnings and missed on expectations – well, sort of.
Keep Reading →
August 11 - News, Stock Analysis - Comments
Billionaire Steven Cohen is bullish on Amag Pharmaceuticals Inc. (NASDAQ:AMAG), as his family office has disclosed a fresh stake in the company.
Keep Reading →
July 27 - Hedge Funds, News - Comments
Sweden-based healthcare focused long/short equity hedge fund Healthinvest Partners AB was founded in 2006 by Anders Hallberg and Carl Bennet.
Keep Reading →
February 15 - Hedge Funds, News - Comments
D. E. Shaw Co., a fund founded by billionaire quant David Shaw, has disclosed its position in AMAG Pharmaceuticals, Inc.
Keep Reading →
January 20 - Hedge Funds, News - Comments
The markets have continued to tumble in the second week of 2016, with all major U.S stock indexes now down today after a mild rally earlier in the day.
Keep Reading →
January 11 - Market Movers, News - Comments
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
December 1 - Hedge Funds, News - Comments
The shareholders of CIT Group Inc. (NYSE:CIT), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Avis Budget Group Inc.
Keep Reading →
November 3 - Market Movers, News - Comments
For the last year or so, many investors have been seeking profitable opportunities in the biotech sector, which has sent the shares of many stocks higher.
Keep Reading →
October 23 - Hedge Funds, News - Comments
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of ...
Keep Reading →
July 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Our research has shown us that hedge funds are particularly adept at generating large returns from small-cap stocks.
Keep Reading →
February 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
Keep Reading →
August 11 - Hedge Funds, News - Comments
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.
Keep Reading →
April 17 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Keep Reading →
March 7 - Hedge Funds, News - Comments
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies.
Keep Reading →
September 9 - News - Comments
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Keep Reading →
August 22 - News - Comments
In today’s marketplace, there are many metrics investors can use to watch stocks. Two of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
July 1 - News - Comments
In today’s marketplace, there are many indicators shareholders can use to watch the equity markets.
Keep Reading →
June 25 - News - Comments
If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.
Keep Reading →
June 19 - News - Comments
SurModics, Inc. (NASDAQ:SRDX) was in 8 hedge funds' portfolio at the end of March.
Keep Reading →
June 14 - News - Comments
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) the right pick for your portfolio? Prominent investors are taking a pessimistic view.
Keep Reading →
June 12 - News - Comments
In the eyes of most investors, hedge funds are assumed to be underperforming, old financial vehicles of years past.
Keep Reading →
June 6 - News - Comments
Gloom, despair, and agony. Shareholders of at least three health-care stocks experienced one or more of these feelings over the past few days.
Keep Reading →
May 28 - News - Comments
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) a good investment today? Investors who are in the know are taking a pessimistic view.
Keep Reading →
April 24 - News - Comments
Is Trinity Biotech plc (ADR) (NASDAQ:TRIB) a sound investment now? Hedge funds are reducing their bets on the stock.
Keep Reading →
April 18 - News - Comments
Is SurModics, Inc. (NASDAQ:SRDX) worth your attention right now? Hedge funds are in a pessimistic mood.
Keep Reading →
April 14 - News - Comments
In the 21st century investor’s toolkit, there are plenty of metrics shareholders can use to monitor their holdings.
Keep Reading →
April 11 - News - Comments